Global Induced Pluripotent Stem Cells iPSCs Market Research Report 2022(Status and Outlook)

June 2022 | 106 pages | ID: GCB9131BF163EN
Bosson Research

Abstracts

Report Overview

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.

The Global Induced Pluripotent Stem Cells iPSCs Market Size was estimated at USD 101.61 million in 2021 and is projected to reach USD 230.63 million by 2028, exhibiting a CAGR of 12.42% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Induced Pluripotent Stem Cells iPSCs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Induced Pluripotent Stem Cells iPSCs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Induced Pluripotent Stem Cells iPSCs market in any manner.

Global Induced Pluripotent Stem Cells iPSCs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

• Fujifilm Holding Corporation (CDI)
• Ncardia
• Sumitomo Dainippon Pharma
• Astellas Pharma Inc
• Fate Therapeutics, Inc
• Pluricell Biotech
• Cell Inspire Biotechnology
• ReproCELL

Market Segmentation (by Type)

• Human iPSCs
• Mouse iPSCs
• Induced Pluripotent Stem Cells (iPSCs)

Market Segmentation (by Application)

• Academic Research
• Drug Development and Discovery
• Toxicity Screening
• Regenerative Medicine
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Induced Pluripotent Stem Cells iPSCs Market
• Overview of the regional outlook of the Induced Pluripotent Stem Cells iPSCs Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Induced Pluripotent Stem Cells iPSCs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Induced Pluripotent Stem Cells iPSCs
1.2 Key Market Segments
  1.2.1 Induced Pluripotent Stem Cells iPSCs Segment by Type
  1.2.2 Induced Pluripotent Stem Cells iPSCs Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 INDUCED PLURIPOTENT STEM CELLS IPSCS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Induced Pluripotent Stem Cells iPSCs Market Size (M USD) Estimates and Forecasts (2017-2028)
  2.1.2 Global Induced Pluripotent Stem Cells iPSCs Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 INDUCED PLURIPOTENT STEM CELLS IPSCS MARKET COMPETITIVE LANDSCAPE

3.1 Global Induced Pluripotent Stem Cells iPSCs Sales by Manufacturers (2017-2022)
3.2 Global Induced Pluripotent Stem Cells iPSCs Revenue Market Share by Manufacturers (2017-2022)
3.3 Induced Pluripotent Stem Cells iPSCs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Induced Pluripotent Stem Cells iPSCs Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Induced Pluripotent Stem Cells iPSCs Sales Sites, Area Served, Product Type
3.6 Induced Pluripotent Stem Cells iPSCs Market Competitive Situation and Trends
  3.6.1 Induced Pluripotent Stem Cells iPSCs Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Induced Pluripotent Stem Cells iPSCs Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 INDUCED PLURIPOTENT STEM CELLS IPSCS INDUSTRY CHAIN ANALYSIS

4.1 Induced Pluripotent Stem Cells iPSCs Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF INDUCED PLURIPOTENT STEM CELLS IPSCS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 INDUCED PLURIPOTENT STEM CELLS IPSCS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Induced Pluripotent Stem Cells iPSCs Sales Market Share by Type (2017-2022)
6.3 Global Induced Pluripotent Stem Cells iPSCs Market Size Market Share by Type (2017-2022)
6.4 Global Induced Pluripotent Stem Cells iPSCs Price by Type (2017-2022)

7 INDUCED PLURIPOTENT STEM CELLS IPSCS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Induced Pluripotent Stem Cells iPSCs Market Sales by Application (2017-2022)
7.3 Global Induced Pluripotent Stem Cells iPSCs Market Size (M USD) by Application (2017-2022)
7.4 Global Induced Pluripotent Stem Cells iPSCs Sales Growth Rate by Application (2017-2022)

8 INDUCED PLURIPOTENT STEM CELLS IPSCS MARKET SEGMENTATION BY REGION

8.1 Global Induced Pluripotent Stem Cells iPSCs Sales by Region
  8.1.1 Global Induced Pluripotent Stem Cells iPSCs Sales by Region
  8.1.2 Global Induced Pluripotent Stem Cells iPSCs Sales Market Share by Region
8.2 North America
  8.2.1 North America Induced Pluripotent Stem Cells iPSCs Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Induced Pluripotent Stem Cells iPSCs Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Induced Pluripotent Stem Cells iPSCs Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Induced Pluripotent Stem Cells iPSCs Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Induced Pluripotent Stem Cells iPSCs Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILED

9.1 Fujifilm Holding Corporation (CDI)
  9.1.1 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells iPSCs Basic Information
  9.1.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells iPSCs Product Overview
  9.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells iPSCs Product Market Performance
  9.1.4 Fujifilm Holding Corporation (CDI) Business Overview
  9.1.5 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells iPSCs SWOT Analysis
  9.1.6 Fujifilm Holding Corporation (CDI) Recent Developments
9.2 Ncardia
  9.2.1 Ncardia Induced Pluripotent Stem Cells iPSCs Basic Information
  9.2.2 Ncardia Induced Pluripotent Stem Cells iPSCs Product Overview
  9.2.3 Ncardia Induced Pluripotent Stem Cells iPSCs Product Market Performance
  9.2.4 Ncardia Business Overview
  9.2.5 Ncardia Induced Pluripotent Stem Cells iPSCs SWOT Analysis
  9.2.6 Ncardia Recent Developments
9.3 Sumitomo Dainippon Pharma
  9.3.1 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells iPSCs Basic Information
  9.3.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells iPSCs Product Overview
  9.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells iPSCs Product Market Performance
  9.3.4 Sumitomo Dainippon Pharma Business Overview
  9.3.5 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells iPSCs SWOT Analysis
  9.3.6 Sumitomo Dainippon Pharma Recent Developments
9.4 Astellas Pharma Inc
  9.4.1 Astellas Pharma Inc Induced Pluripotent Stem Cells iPSCs Basic Information
  9.4.2 Astellas Pharma Inc Induced Pluripotent Stem Cells iPSCs Product Overview
  9.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells iPSCs Product Market Performance
  9.4.4 Astellas Pharma Inc Business Overview
  9.4.5 Astellas Pharma Inc Induced Pluripotent Stem Cells iPSCs SWOT Analysis
  9.4.6 Astellas Pharma Inc Recent Developments
9.5 Fate Therapeutics, Inc
  9.5.1 Fate Therapeutics, Inc Induced Pluripotent Stem Cells iPSCs Basic Information
  9.5.2 Fate Therapeutics, Inc Induced Pluripotent Stem Cells iPSCs Product Overview
  9.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells iPSCs Product Market Performance
  9.5.4 Fate Therapeutics, Inc Business Overview
  9.5.5 Fate Therapeutics, Inc Induced Pluripotent Stem Cells iPSCs SWOT Analysis
  9.5.6 Fate Therapeutics, Inc Recent Developments
9.6 Pluricell Biotech
  9.6.1 Pluricell Biotech Induced Pluripotent Stem Cells iPSCs Basic Information
  9.6.2 Pluricell Biotech Induced Pluripotent Stem Cells iPSCs Product Overview
  9.6.3 Pluricell Biotech Induced Pluripotent Stem Cells iPSCs Product Market Performance
  9.6.4 Pluricell Biotech Business Overview
  9.6.5 Pluricell Biotech Recent Developments
9.7 Cell Inspire Biotechnology
  9.7.1 Cell Inspire Biotechnology Induced Pluripotent Stem Cells iPSCs Basic Information
  9.7.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells iPSCs Product Overview
  9.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells iPSCs Product Market Performance
  9.7.4 Cell Inspire Biotechnology Business Overview
  9.7.5 Cell Inspire Biotechnology Recent Developments
9.8 ReproCELL
  9.8.1 ReproCELL Induced Pluripotent Stem Cells iPSCs Basic Information
  9.8.2 ReproCELL Induced Pluripotent Stem Cells iPSCs Product Overview
  9.8.3 ReproCELL Induced Pluripotent Stem Cells iPSCs Product Market Performance
  9.8.4 ReproCELL Business Overview
  9.8.5 ReproCELL Recent Developments

10 INDUCED PLURIPOTENT STEM CELLS IPSCS MARKET FORECAST BY REGION

10.1 Global Induced Pluripotent Stem Cells iPSCs Market Size Forecast
10.2 Global Induced Pluripotent Stem Cells iPSCs Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Country
  10.2.3 Asia Pacific Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Region
  10.2.4 South America Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Induced Pluripotent Stem Cells iPSCs by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)

11.1 Global Induced Pluripotent Stem Cells iPSCs Market Forecast by Type (2022-2028)
  11.1.1 Global Forecasted Sales of Induced Pluripotent Stem Cells iPSCs by Type (2022-2028)
  11.1.2 Global Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Type (2022-2028)
  11.1.3 Global Forecasted Price of Induced Pluripotent Stem Cells iPSCs by Type (2022-2028)
11.2 Global Induced Pluripotent Stem Cells iPSCs Market Forecast by Application (2022-2028)
  11.2.1 Global Induced Pluripotent Stem Cells iPSCs Sales (K Units) Forecast by Application
  11.2.2 Global Induced Pluripotent Stem Cells iPSCs Market Size (M USD) Forecast by Application (2022-2028)

12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Induced Pluripotent Stem Cells iPSCs Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Induced Pluripotent Stem Cells iPSCs Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Induced Pluripotent Stem Cells iPSCs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Induced Pluripotent Stem Cells iPSCs Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Induced Pluripotent Stem Cells iPSCs Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells iPSCs as of 2021)
Table 10. Global Market Induced Pluripotent Stem Cells iPSCs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Induced Pluripotent Stem Cells iPSCs Sales Sites and Area Served
Table 12. Manufacturers Induced Pluripotent Stem Cells iPSCs Product Type
Table 13. Global Induced Pluripotent Stem Cells iPSCs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Induced Pluripotent Stem Cells iPSCs
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Induced Pluripotent Stem Cells iPSCs Market Challenges
Table 22. Market Restraints
Table 23. Global Induced Pluripotent Stem Cells iPSCs Sales by Type (K Units)
Table 24. Global Induced Pluripotent Stem Cells iPSCs Market Size by Type (M USD)
Table 25. Global Induced Pluripotent Stem Cells iPSCs Sales (K Units) by Type (2017-2022)
Table 26. Global Induced Pluripotent Stem Cells iPSCs Sales Market Share by Type (2017-2022)
Table 27. Global Induced Pluripotent Stem Cells iPSCs Market Size (M USD) by Type (2017-2022)
Table 28. Global Induced Pluripotent Stem Cells iPSCs Market Size Share by Type (2017-2022)
Table 29. Global Induced Pluripotent Stem Cells iPSCs Price (USD/Unit) by Type (2017-2022)
Table 30. Global Induced Pluripotent Stem Cells iPSCs Sales (K Units) by Application
Table 31. Global Induced Pluripotent Stem Cells iPSCs Market Size by Application
Table 32. Global Induced Pluripotent Stem Cells iPSCs Sales by Application (2017-2022) & (K Units)
Table 33. Global Induced Pluripotent Stem Cells iPSCs Sales Market Share by Application (2017-2022)
Table 34. Global Induced Pluripotent Stem Cells iPSCs Sales by Application (2017-2022) & (M USD)
Table 35. Global Induced Pluripotent Stem Cells iPSCs Market Share by Application (2017-2022)
Table 36. Global Induced Pluripotent Stem Cells iPSCs Sales Growth Rate by Application (2017-2022)
Table 37. Global Induced Pluripotent Stem Cells iPSCs Sales by Region (2017-2022) & (K Units)
Table 38. Global Induced Pluripotent Stem Cells iPSCs Sales Market Share by Region (2017-2022)
Table 39. North America Induced Pluripotent Stem Cells iPSCs Sales by Country (2017-2022) & (K Units)
Table 40. Europe Induced Pluripotent Stem Cells iPSCs Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Induced Pluripotent Stem Cells iPSCs Sales by Region (2017-2022) & (K Units)
Table 42. South America Induced Pluripotent Stem Cells iPSCs Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Induced Pluripotent Stem Cells iPSCs Sales by Region (2017-2022) & (K Units)
Table 44. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells iPSCs Basic Information
Table 45. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells iPSCs Product Overview
Table 46. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells iPSCs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Fujifilm Holding Corporation (CDI) Business Overview
Table 48. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells iPSCs SWOT Analysis
Table 49. Fujifilm Holding Corporation (CDI) Recent Developments
Table 50. Ncardia Induced Pluripotent Stem Cells iPSCs Basic Information
Table 51. Ncardia Induced Pluripotent Stem Cells iPSCs Product Overview
Table 52. Ncardia Induced Pluripotent Stem Cells iPSCs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Ncardia Business Overview
Table 54. Ncardia Induced Pluripotent Stem Cells iPSCs SWOT Analysis
Table 55. Ncardia Recent Developments
Table 56. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells iPSCs Basic Information
Table 57. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells iPSCs Product Overview
Table 58. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells iPSCs Sales (K Units), Market Size (M USD), Price
(USD/Unit) and Gross Margin (2017-2022)
Table 59. Sumitomo Dainippon Pharma Business Overview
Table 60. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells iPSCs SWOT Analysis
Table 61. Sumitomo Dainippon Pharma Recent Developments
Table 62. Astellas Pharma Inc Induced Pluripotent Stem Cells iPSCs Basic Information
Table 63. Astellas Pharma Inc Induced Pluripotent Stem Cells iPSCs Product Overview
Table 64. Astellas Pharma Inc Induced Pluripotent Stem Cells iPSCs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Astellas Pharma Inc Business Overview
Table 66. Astellas Pharma Inc Induced Pluripotent Stem Cells iPSCs SWOT Analysis
Table 67. Astellas Pharma Inc Recent Developments
Table 68. Fate Therapeutics, Inc Induced Pluripotent Stem Cells iPSCs Basic Information
Table 69. Fate Therapeutics, Inc Induced Pluripotent Stem Cells iPSCs Product Overview
Table 70. Fate Therapeutics, Inc Induced Pluripotent Stem Cells iPSCs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Fate Therapeutics, Inc Business Overview
Table 72. Fate Therapeutics, Inc Induced Pluripotent Stem Cells iPSCs SWOT Analysis
Table 73. Fate Therapeutics, Inc Recent Developments
Table 74. Pluricell Biotech Induced Pluripotent Stem Cells iPSCs Basic Information
Table 75. Pluricell Biotech Induced Pluripotent Stem Cells iPSCs Product Overview
Table 76. Pluricell Biotech Induced Pluripotent Stem Cells iPSCs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Pluricell Biotech Business Overview
Table 78. Pluricell Biotech Recent Developments
Table 79. Cell Inspire Biotechnology Induced Pluripotent Stem Cells iPSCs Basic Information
Table 80. Cell Inspire Biotechnology Induced Pluripotent Stem Cells iPSCs Product Overview
Table 81. Cell Inspire Biotechnology Induced Pluripotent Stem Cells iPSCs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Cell Inspire Biotechnology Business Overview
Table 83. Cell Inspire Biotechnology Recent Developments
Table 84. ReproCELL Induced Pluripotent Stem Cells iPSCs Basic Information
Table 85. ReproCELL Induced Pluripotent Stem Cells iPSCs Product Overview
Table 86. ReproCELL Induced Pluripotent Stem Cells iPSCs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. ReproCELL Business Overview
Table 88. ReproCELL Recent Developments
Table 89. Global Induced Pluripotent Stem Cells iPSCs Sales Forecast by Region (K Units)
Table 90. Global Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Region (M USD)
Table 91. North America Induced Pluripotent Stem Cells iPSCs Sales Forecast by Country (2022-2028) & (K Units)
Table 92. North America Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Country (2022-2028) & (M USD)
Table 93. Europe Induced Pluripotent Stem Cells iPSCs Sales Forecast by Country (2022-2028) & (K Units)
Table 94. Europe Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Country (2022-2028) & (M USD)
Table 95. Asia Pacific Induced Pluripotent Stem Cells iPSCs Sales Forecast by Region (2022-2028) & (K Units)
Table 96. Asia Pacific Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Region (2022-2028) & (M USD)
Table 97. South America Induced Pluripotent Stem Cells iPSCs Sales Forecast by Country (2022-2028) & (K Units)
Table 98. South America Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Country (2022-2028) & (M USD)
Table 99. Middle East and Africa Induced Pluripotent Stem Cells iPSCs Consumption Forecast by Country (2022-2028) & (Units)
Table 100. Middle East and Africa Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Country (2022-2028) & (M USD)
Table 101. Global Induced Pluripotent Stem Cells iPSCs Sales Forecast by Type (2022-2028) & (K Units)
Table 102. Global Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Type (2022-2028) & (M USD)
Table 103. Global Induced Pluripotent Stem Cells iPSCs Price Forecast by Type (2022-2028) & (USD/Unit)
Table 104. Global Induced Pluripotent Stem Cells iPSCs Sales (K Units) Forecast by Application (2022-2028)
Table 105. Global Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Induced Pluripotent Stem Cells iPSCs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Induced Pluripotent Stem Cells iPSCs Market Size (M USD), 2017-2028
Figure 5. Global Induced Pluripotent Stem Cells iPSCs Market Size (M USD) (2017-2028)
Figure 6. Global Induced Pluripotent Stem Cells iPSCs Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Induced Pluripotent Stem Cells iPSCs Market Size (M USD) by Country (M USD)
Figure 11. Induced Pluripotent Stem Cells iPSCs Sales Share by Manufacturers in 2020
Figure 12. Global Induced Pluripotent Stem Cells iPSCs Revenue Share by Manufacturers in 2020
Figure 13. Induced Pluripotent Stem Cells iPSCs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Induced Pluripotent Stem Cells iPSCs Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Induced Pluripotent Stem Cells iPSCs Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Induced Pluripotent Stem Cells iPSCs Market Share by Type
Figure 18. Sales Market Share of Induced Pluripotent Stem Cells iPSCs by Type (2017-2022)
Figure 19. Sales Market Share of Induced Pluripotent Stem Cells iPSCs by Type in 2021
Figure 20. Market Size Share of Induced Pluripotent Stem Cells iPSCs by Type (2017-2022)
Figure 21. Market Size Market Share of Induced Pluripotent Stem Cells iPSCs by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Induced Pluripotent Stem Cells iPSCs Market Share by Application
Figure 24. Global Induced Pluripotent Stem Cells iPSCs Sales Market Share by Application (2017-2022)
Figure 25. Global Induced Pluripotent Stem Cells iPSCs Sales Market Share by Application in 2021
Figure 26. Global Induced Pluripotent Stem Cells iPSCs Market Share by Application (2017-2022)
Figure 27. Global Induced Pluripotent Stem Cells iPSCs Market Share by Application in 2020
Figure 28. Global Induced Pluripotent Stem Cells iPSCs Sales Growth Rate by Application (2017-2022)
Figure 29. Global Induced Pluripotent Stem Cells iPSCs Sales Market Share by Region (2017-2022)
Figure 30. North America Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Induced Pluripotent Stem Cells iPSCs Sales Market Share by Country in 2020
Figure 32. U.S. Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Induced Pluripotent Stem Cells iPSCs Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Induced Pluripotent Stem Cells iPSCs Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Induced Pluripotent Stem Cells iPSCs Sales Market Share by Country in 2020
Figure 37. Germany Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Induced Pluripotent Stem Cells iPSCs Sales Market Share by Region in 2020
Figure 44. China Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (K Units)
Figure 50. South America Induced Pluripotent Stem Cells iPSCs Sales Market Share by Country in 2020
Figure 51. Brazil Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Induced Pluripotent Stem Cells iPSCs Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Induced Pluripotent Stem Cells iPSCs Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Induced Pluripotent Stem Cells iPSCs Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Induced Pluripotent Stem Cells iPSCs Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Induced Pluripotent Stem Cells iPSCs Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Induced Pluripotent Stem Cells iPSCs Market Share Forecast by Type (2022-2028)
Figure 65. Global Induced Pluripotent Stem Cells iPSCs Sales Forecast by Application (2022-2028)
Figure 66. Global Induced Pluripotent Stem Cells iPSCs Market Share Forecast by Application (2022-2028)